ASO Author Reflections: Albumin-Bilirubin Grade is an Independent Prognostic Factor Complementary to CA19-9 for Pancreatic Cancer Patients

被引：0
|
作者：
Taisuke Imamura
Yukiyasu Okamura
Teiichi Sugiura
Yusuke Yamamoto
Takaaki Ito
Ryo Ashida
Katsuhisa Ohgi
Shimpei Ohtsuka
Katsuhiko Uesaka
机构：
[1] Shizuoka Cancer Center,Division of Hepato
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6236 / 6237
页数：1
相关论文
共 50 条
  • [1] ASO Author Reflections: Albumin-Bilirubin Grade is an Independent Prognostic Factor Complementary to CA19-9 for Pancreatic Cancer Patients
    Imamura, Taisuke
    Okamura, Yukiyasu
    Sugiura, Teiichi
    Yamamoto, Yusuke
    Ito, Takaaki
    Ashida, Ryo
    Ohgi, Katsuhisa
    Ohtsuka, Shimpei
    Uesaka, Katsuhiko
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 6236 - 6237
  • [2] Albumin-bilirubin grade is an independent prognostic factor for small lung cell cancer
    Liu, Shicheng
    Zhao, Qingtao
    Wang, Zengming
    Zhao, Bin
    Zhang, Xiaopeng
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (02)
  • [3] ASO Author Reflections: Albumin-Bilirubin Grade and Myosteatosis as Potential Cancer Cachexia-Related Indicators in Patients with Colorectal Cancer
    Koh, Hwa-Hee
    Kang, Jeonghyun
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (06) : 3877 - 3878
  • [4] Preoperative Albumin-Bilirubin Grade as a Useful Prognostic Indicator in Patients With Pancreatic Cancer
    Yagyu, Takuki
    Saito, Hiroaki
    Sakamoto, Teruhisa
    Uchinaka, Ei
    Morimoto, Masaki
    Amisaki, Masataka
    Watanabe, Joji
    Tokuyasu, Naruo
    Honjo, Soichiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2019, 39 (03) : 1441 - 1446
  • [5] CA19-9 is an independent prognostic factor for locally advanced pancreatic cancer patients treated with chemoradiotherapy
    Chung, M. J.
    Hong, S. P.
    Bang, S. M.
    Park, S. W.
    Seoung, J. S.
    Lee, W. J.
    Chung, J. B.
    Song, S. Y.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A129 - A129
  • [6] ASO Author Reflections: Serum CA19-9 Utility in Pancreatic Adenocarcinoma in Patients Undergoing Neoadjuvant Therapy
    Al Abbas, Amr I.
    Hogg, Melissa E.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (06) : 2015 - 2016
  • [7] ASO Author Reflections: Serum CA19-9 Utility in Pancreatic Adenocarcinoma in Patients Undergoing Neoadjuvant Therapy
    Amr I. Al Abbas
    Melissa E. Hogg
    Annals of Surgical Oncology, 2020, 27 : 2015 - 2016
  • [8] ASO Author Reflections: Prognostic Role of Preoperative Duke Pancreatic Monoclonal Antigen Type 2 Values in Patients with Pancreatic Cancer: Focusing on the Usefulness in Patients with Normal CA19-9
    Shimizu, Yuji
    Sugiura, Teiichi
    Ashida, Ryo
    Ohgi, Katsuhisa
    Yamada, Mihoko
    Otsuka, Shimpei
    Uesaka, Katsuhiko
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (09) : 5801 - 5802
  • [9] ASO Author Reflections: Prognostic Role of Preoperative Duke Pancreatic Monoclonal Antigen Type 2 Values in Patients with Pancreatic Cancer: Focusing on the Usefulness in Patients with Normal CA19-9
    Yuji Shimizu
    Teiichi Sugiura
    Ryo Ashida
    Katsuhisa Ohgi
    Mihoko Yamada
    Shimpei Otsuka
    Katsuhiko Uesaka
    Annals of Surgical Oncology, 2023, 30 : 5801 - 5802
  • [10] ASO Author Reflections: A New Prognostic Factor for Pancreatic Cancer
    Shohei Yoshiya
    Shinji Itoh
    Tomoharu Yoshizumi
    Masaki Mori
    Annals of Surgical Oncology, 2021, 28 : 3208 - 3208
12345